View More VRTX Earnings Transcripts Related Stocks NASDAQ: ILMN Illumina Market Cap $21B Current Price $131.20 NASDAQ: GILD Gilead Sciences Market Cap $105B Current Price $83.94 NASDAQ: EXEL Exelixis Market Cap $8B Current Price $26.42 NYSE: BMY Bristol Myers Squibb Market Cap ...
Get Vertex Pharmaceuticals Inc (VRTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Industry:Pharmaceuticals CEO:Reshma Kewalramani Website:https://www.vrtx.com/ Ticker:VRTX Company type:Public Revenues ($M):$9,869 Profits ($M):$3,620 Market value ($M):$107,975 Number of employees:5,236 Market value as of March 28, 2024.Vertex Pharmaceuticals stock chartVertex...
VRTX ▲1.17% 481.715.56 REGN ▲1.67% 1,015.6716.65 GILD ▲0.33% 84.950.28 IDXX ▲0.63% 476.272.99 ALNY ▲2.05% 284.325.70 ARGX ▲1.79% 536.709.45 BNTX ▲1.82% 120.522.15 AMGN ▲2.29% 328.357.34 ISRG ▲0.19% 484.780.94NewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice Hi...
VRTX ▼-3.15% 483.00-15.73 REGN ▼-0.76% 990.68-7.55 GILD ▼-0.73% 86.72-0.64 ALNY ▼-0.28% 295.93-0.82 IDXX ▼-0.49% 457.74-2.27 ARGX ▲3.89% 565.0021.16 BIIB ▲0.32% 190.160.61 LIN ▲0.08% 486.450.39 ISRG ▲10.01% 521.1547.42 SNY ▲0.13% 54.930.07 VRTX ▼-3.15% 483.00-15.73...
Analyst Ratings Sell Under Hold Over Buy Number of Ratings 6 Full Ratings Recent News MarketWatch Dow Jones Edgewise Therapeutics Shares Rise on Positive Results for Heart-Disease Treatment Sep. 19, 2024 at 8:06 a.m. ET Edgewise Therapeutics started at buy with $25 stock price target...
VRTX Stock 12 Month Forecast $470.89 ▼(-4.07% Downside) Based on 22 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $470.89 with a high forecast of $555.00 and a low forecast of $325.00. The average price...
isrg view more valuation measures as of 8/1/2024 market cap 160.24b enterprise value 155.49b trailing p/e 77.48 forward p/e 71.94 peg ratio (5yr expected) 4.66 price/sales (ttm) 21.41 price/book (mrq) 10.89 enterprise value/revenue 20.53 enterprise value/ebitda 64.64 financial highlights ...
NASDAQ: VRTX Vertex Pharmaceuticals Market Cap $120B Current Price $463.15 NASDAQ: ILMN Illumina Market Cap $21B Current Price $132.27 NASDAQ: EXEL Exelixis Market Cap $7B Current Price $26.24 NYSE: BMY Bristol Myers Squibb Market Cap